SC 13G
SC 13G Filing
- Company
- AYTU BIOPHARMA, INC
- Filed
- August 24, 2017
- Accession Number
- 0000919574-17-006366
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →